Condition: Inappropriate Prescribing · Reflux Disease · Proton Pump Inhibitors · Sponsor: University of Bern
The DROPIT Trial is an interventional, open-labelled, cluster-randomized controlled trial conducted in the Swiss primary care setting. It aims to evaluate an intervention to guide the deprescribing of inappropriate proton-pump inhibitors (PPIs). Therefore, the trial investigates whether the study intervention leads to the deprescribing of inappropriate PPI prescription while ensuring noninferiority safety, in comparison to usual care. Additionally, the trail aims to investigate the intervention's impact on other clinical aspects, as well as addressing features of the implementation of the intervention and its cost-effectiveness.
This description comes directly from the study's public registry record.
Sven Streit, Prof. Dr med. Dr. phil. · +41 31 684 58 75 · sven.streit@unibe.ch
Always discuss trial participation with your own doctor first.
| Prof. Dr. med. Dr. phil. Sven Streit | Bern, Switzerland | Not Yet Recruiting |
| University of Bern | Bern, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06129474